DCALPharmaceuticals
Dishman Carbogen Amcis Ltd — PE Ratio & Valuation Analysis
₹129.97
-7.38%
Current P/E24.96xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E630.8x96.0% below avg
✅
21.4% Discount to Industry
DCAL P/E 24.96x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.21 | ₹248 | 1179x |
| 2022 | ₹1.15 | ₹95 | 82.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Dishman Carbogen Amcis Ltd Valuation
Dishman Carbogen Amcis Ltd (DCAL) currently trades at 24.96x earnings. The Pharmaceuticals sector average PE is 31.77x. DCAL is trading at a discount to peers — may indicate relative value. Historically, DCAL has traded at an average PE of 630.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-0.32%
Dividend Yield
0.00%
More on Dishman Carbogen Amcis Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.